Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00761826 · ClinicalTrials.gov registry record · NA

Study of the MEL 80 Excimer Laser Using LASIK in the Treatment of Mixed Astigmatism

A NA study, sponsored by Carl Zeiss Meditec.

Completed
Registry status
NA
Development phase
126
Enrollment target

NCT00761826: Completed NA study, sponsored by Carl Zeiss Meditec.

NCT00761826 is a NA study that has completed, run by Carl Zeiss Meditec. The registered enrollment target is 126 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00761826, a NA study, has completed, sponsored by Carl Zeiss Meditec.

COMPLETED
Registry status
NA
Development phase
126 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether the MEL 80 Excimer Laser is effective in the treatment of mixed astigmatism up to 6.0 D, when used as part of the Laser In Situ Keratomileusis (LASIK) procedure.

Interventions

  • DEVICE MEL 80 Mixed Astigmatism Treatment

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2007-01
Est. Completion 2009-12
Phase NA
Carl Zeiss Meditec

18 total trials

What the finished NCT00761826 record still lists

NCT00761826 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 1 intervention - of which MEL 80 Mixed Astigmatism Treatment is the first listed.

NCT00761826 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00761826 about?

NCT00761826 is a clinical study titled "Study of the MEL 80 Excimer Laser Using LASIK in the Treatment of Mixed Astigmatism". The purpose of this study is to determine whether the MEL 80 Excimer Laser is effective in the treatment of mixed astigmatism up to 6.0 D, when used as part of the Laser In Situ Keratomileusis (LASIK) procedure.

What is the current status of trial NCT00761826?

This trial is currently completed. It is a NA study. The enrollment target is 126 participants. The study started on 2007-01. Estimated completion is 2009-12.

What interventions are being tested in trial NCT00761826?

The interventions under investigation include: MEL 80 Mixed Astigmatism Treatment (DEVICE).

Who is sponsoring clinical trial NCT00761826?

This trial is sponsored by Carl Zeiss Meditec, which has 18 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00761826's enrollment target sits among peer trials

126 749th of 2000 higher than 1,248 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01873131 · 126 participants · NA

    A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn

  • NCT02621645 · 126 participants · Phase 4

    TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

  • NCT03838107 · 126 participants

    Markers of Trajectory in Pediatric CRPS

  • NCT03906422 · 126 participants · NA

    Comparison of Patient-reported Pain After Initial Archwire Placement

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00761826, the US trial registry maintained by the National Library of Medicine. NCT00761826 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.